However, this article posits that a follow‐up sampling for early detection of gene mutations, alterations and increases in proliferation indexes (Ki67, HER2) is of utmost importance for the prevention of BC relapse or metastasis and improvement of prognosis, by timely detecting drug resistance [6, 10, 16]. Here, MKI67 is linked to breast cancer.